In triple negative (ERα‐, PR‐, HER2‐) breast cancer cell lines, ERα‐36 promotes proliferation via rapid epidermal growth factor receptor (EGFR)‐extracellular signal‐regulated kinase (ERK) signalling.22 Here, EGFR is linked to breast carcinoma.